# Stage 03 NLP Evaluation Report

## 1. Objective
The Stage 03 Evaluation phase benchmarks the predictive validity of the text classifier and NER model. The purpose is to rigorously measure technical performance prior to Integration. 

## 2. PDF Requirement
The Evaluation Engineer role specified in the PDF explicitly requires:
- Benchmarking precision and recall on held-out test data
- Confusion matrices and edge-case failure analysis
- Compiling the Clinical Misinterpretation Audit Log

## 3. Evaluation Dataset
- **Source**: `stage3_nlp/data/splits/test_ids.csv`
- **Size**: 1,499 records.
- **Split Strategy**: 15% stratified hold-out from the overall 9,990 valid data rows.
- **Classification Labels**: `LOW`, `MODERATE`, `HIGH`.
- **Entity Types**: `GENE_MUTATION`, `DRUG_NAME`, `DOSAGE_LEVEL`, `ADVERSE_EVENT`.

## 4. Urgency Classifier
- **Model Assessed**: Logistic Regression on `ngram_range=(1,2)` TF-IDF vectors (balanced class weighting).
- **Evaluation Methodology**: Standard macro- and weighted-averages for overall effectiveness and detailed per-class results to identify class imbalances (such as distinguishing MODERATE from HIGH).

## 5. Classification Metrics
Overall classifier performance on the 1,499 held-out items:
- **Accuracy**: 89.0%
- **Macro Precision**: 83.2%
- **Macro Recall**: 87.2%
- **Macro F1**: 84.8%

## 6. Confusion Matrix
The generated `classifier_confusion_matrix.png` explicitly enumerates classification overlap. Key observation:
The primary overlap happens between adjacent urgency levels, often triggered by overlapping clinical descriptions (e.g., patient stable but history of severity).

## 7. NER Evaluation
- **Methodology**: Exact span-matching. A True Positive requires exact character alignment `(start, end)` AND exact label match. 
- **Entity Level Metrics**:
  - `GENE_MUTATION`: F1 = 89.9% (725 support)
  - `DRUG_NAME`: F1 = 100% (1103 support)
  - `DOSAGE_LEVEL`: F1 = 100% (617 support)
  - `ADVERSE_EVENT`: F1 = 100% (3176 support)
- **Overall**: 98.7% overall Precision / Recall / F1.

## 8. Error Analysis
False Positives and False Negatives almost entirely cluster around the `GENE_MUTATION` class. Synthetically appended genetic nomenclature often bleeds into neighboring token constraints, resulting in minor boundaries misalignment. 

## 9. Edge Cases
From the `edge_case_analysis.py` pipeline, 165 classification edge-case records were isolated. Common failure patterns observed:
- `MISCLASSIFIED_HIGH_AS_LOW` or `MODERATE_AS_LOW`.
- Complex negations that cross punctuation boundaries ("patient had severe nausea, but denies pain today").

## 10. Misinterpretation Audit Log
We aggregated 238 explicit entries into `misinterpretation_audit_log.csv`. 
- 165 urgency misclassification rows.
- 73 NER boundary / false-positive errors targeting the `GENE_MUTATION` class. 
This log satisfies the major Stage 03 requirement for tracking model drift or safety vulnerabilities.

## 11. Software Validation
The implementation logic was vetted via `test_evaluation.py`. Tests strictly verify that all artifact structures conform to requirements without internet dependencies. (100% passing rate across all 27 Stage 3 tests).

## 12. Limitations
**CRITICAL**: The dataset and annotations are entirely synthetic. The evaluation results represent purely technical performance benchmarks over synthetic syntax and rule-based vocabulary. These metrics **do not establish clinical validity**, and this model is strictly **NOT** clinically validated.

## 13. Next Stage
With NLP modeling and evaluation successfully finalized, the project is staged for the **Integration Engineer** phase, focusing on creating FastAPI/React infrastructure for live interaction.
